2005European Journal Of HaematologyRequires access

Philadelphia‐chromosome positive thrombocythemia in a child

Pravas Mishra, M. Mahapatra, Rajat Kumar, Ashish Dixit, Tathagat Chatterjee, Seema Tyagi, Dharma R. Choudhry, Sudha Sazawal, V. P. Choudhry

Open publisher page 6 citations

Abstract

Philadelphia-chromosome positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood has been described in adults. It is rare in children. We present a case of Philadelphia positive thrombocythemia in a child who was managed with a combination of imatinib and hydroxyurea. Although a reduction in the BCR-ABL transcript was documented, the thrombocytosis was refractory to imatinib alone and required the addition of hydroxyurea.

About this research paper

What this paper is about

Philadelphia-chromosome positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood has been described in adults. It is rare in children. We present a case of Philadelphia positive thrombocythemia in a child who was managed with a combination of imatinib and hydroxyurea. Although a reduction in the BCR-ABL transcript was documented, the thrombocytosis was refractory to imatinib alone and required the addition of hydroxyurea.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Philadelphia-chromosome positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood has been described in adults. It is rare in children. We present a case of Philadelphia positive thrombocythemia in a child who was managed with a combination of imatinib and hydroxyurea. Although a reduction in the BCR-ABL transcript was documented, the thrombocytosis was refractory to imatinib alone and required the addition of hydroxyurea.

Key concepts: Essential thrombocythemia, Thrombocytosis, Imatinib, Medicine, Philadelphia chromosome, Myeloid leukemia, Anagrelide, Polycythemia vera

Related papers

Back to paper searchBrowse research topicsOriginal source
Philadelphia‐chromosome positive thrombocythemia in a child — Research Paper | ScholarLens